News
-
Endomag raises $20m Series D scale-up capital
Draper Esprit has led a blockbusting $20 million Series D round for Cambridge based biotech business Endomag whose technology is transforming cancer... Read More
-
Paediatric HealthTech nets £10k bonus to help children with hearing loss
Babraham Research Campus, AstraZeneca and CMS Ventures joined forces to offer the current cohort of [email protected] life science startups the... Read More
-
Virus and bacteria killer CodiKoat joins race to EpiCentre
Start-up company CodiKoat, which has developed a groundbreaking technology that kills viruses and bacteria on surfaces within seconds, is the first... Read More
-
Porotech primed for $multibillion AR and headset markets
University of Cambridge spin-out Porotech has launched its first product based on its breakthrough gallium nitride (GaN) production technique that is... Read More
-
Achilles takes funding haul to c£153m in 14 months
Achilles Therapeutics has taken its funding haul to just under £153 million in 14 months with a £52.7m Series C. It raised £100m in September 2019... Read More
-
Bicycle CLIPS cost €4m+
Bicycle Therapeutics plc in Cambridge has settled IP disputes worldwide with Dutch company Pepscan Systems B.V. regarding Bicycle’s use of Pepscan’s... Read More
-
Talks could trigger COVID test rollout
Cambridge biotech Avacta Group is in discussions with commercial partners to establish a route to market for a CE marked BAMS COVID-19 test that can... Read More
-
Treatt boosts full-year profits despite pandemic
East of England manufacturer Treatt plc has exceeded its own expectations with excellent full-year results that defy normal business gravity given... Read More
-
Stansted eyes zero-emission aircraft in the next decade
Next-generation, zero-emission planes could be operating out of Stansted within the next 10–15 years thanks to a new competition by the airport’s... Read More
-
CMR Surgical robot arm tops 1,000 operations landmark
Versius, the next-generation surgical robot from Cambridge, has been used to successfully conduct over 1,000 surgical procedures in hospitals across... Read More
-
TTP seeks investment and partners for new COVID screening tech
Product design innovator The Technology Partnership Plc (TTP), is seeking go-to-market partnerships for CoTest, a new pooled screening technology for... Read More
-
Time to Shine as university unveils new sustainability institute chief
The University of Cambridge Institute for Sustainability Leadership (CISL) has revealed that Clare Shine will succeed Dame Polly Courtice as its new... Read More
-
Oxbridge vaccine success adds more hope to global COVID campaign
Cambridge’s AstraZeneca and partner Oxford University report good progress from the latest clinical trials of their vaccine against COVID-19 and are... Read More
-
CE chief forecasts more global glory for Cambridge as search for successor gets underway
Cambridge Enterprise, which commercialises technology emanating from the university, has triggered an early search for a CEO to replace Dr Tony Raven... Read More
-
F-star makes NASDAQ bow as Cambridge steps up US parade
F-star Therapeutics in Cambridge has wrapped up its fusion with Spring Bank Pharmaceuticals in Massachusetts and makes its NASDAQ bow tomorrow.... Read More
-
Oceans of opportunity as waterways monitor pioneer scales globally
A Cambridge sensory technology business is taking a new product to market in a landmark move that holds exciting opportunities for the planet. ANB... Read More
-
Blood diamond: Milestone for Closed Loop Medicine in hypertension trial
Closed Loop Medicine has recruited its first patient into a novel PhIV precision medicine interventional clinical trial for patients with high blood... Read More
-
Featurespace leads region’s Technology Fast 50 cohort
Cambridge-based provider of financial crime prevention software, Featurespace™, has been named the fastest growing technology company in the... Read More
-
Cambridge technology preserves Russian art
Bleeding edge technology from Cambridge UK terahertz pioneer TeraView is being deployed to preserve Russian art. The long-established and growing... Read More
-
DefiniGEN US and UK growth spurred by £3.25m funding
Cambridge University spin-out DefiniGEN, which provides human cell products and services, has closed a £3.25 million funding round to accelerate its... Read More